A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis.

Goodman, Aaron M; Rust, Megan; Costello, Caitlin; Ball, Edward D

Goodman, Aaron M; Rust, Megan; Costello, Caitlin; Ball, Edward D.

Oncology (Williston Park) ; 31(2): 122-4, 126-8, 2017 02 15.

Article in En | MEDLINE | ID: mdl-28205192

Subject(s)

Anemia/chemically induced; Antineoplastic Agents, Immunological/adverse effects; Ipilimumab/adverse effects; Primary Myelofibrosis/drug therapy; Graft vs Host Disease/etiology; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Male; Middle Aged; Recurrence

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Primary Myelofibrosis / Ipilimumab / Antineoplastic Agents, Immunological / Anemia Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: Oncology (Williston Park) Journal subject: NEOPLASIAS Year: 2017 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links